Heart study aims to cut bleeding risk for seniors by shortening blood thinner regimen
NCT ID NCT07164859
Summary
This study is testing if a much shorter course of dual blood-thinning therapy is as safe and effective as the standard longer course for seniors who get a heart stent. It will enroll 1,700 patients aged 65 and older. One group will take two blood thinners for just 7 days, then one blood thinner alone, while the other follows the standard 3-12 month dual therapy, to see if the shorter course reduces bleeding without increasing heart risks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caen University Hospital
Caen, 14000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.